648 related articles for article (PubMed ID: 27799632)
1. Pulmonary fibrosis in the era of stratified medicine.
Mathai SK; Newton CA; Schwartz DA; Garcia CK
Thorax; 2016 Dec; 71(12):1154-1160. PubMed ID: 27799632
[TBL] [Abstract][Full Text] [Related]
2. Analysis of protein-altering variants in telomerase genes and their association with MUC5B common variant status in patients with idiopathic pulmonary fibrosis: a candidate gene sequencing study.
Dressen A; Abbas AR; Cabanski C; Reeder J; Ramalingam TR; Neighbors M; Bhangale TR; Brauer MJ; Hunkapiller J; Reeder J; Mukhyala K; Cuenco K; Tom J; Cowgill A; Vogel J; Forrest WF; Collard HR; Wolters PJ; Kropski JA; Lancaster LH; Blackwell TS; Arron JR; Yaspan BL
Lancet Respir Med; 2018 Aug; 6(8):603-614. PubMed ID: 29891356
[TBL] [Abstract][Full Text] [Related]
3. The genetic basis of idiopathic pulmonary fibrosis.
Kropski JA; Blackwell TS; Loyd JE
Eur Respir J; 2015 Jun; 45(6):1717-27. PubMed ID: 25837031
[TBL] [Abstract][Full Text] [Related]
4. A common MUC5B promoter polymorphism and pulmonary fibrosis.
Seibold MA; Wise AL; Speer MC; Steele MP; Brown KK; Loyd JE; Fingerlin TE; Zhang W; Gudmundsson G; Groshong SD; Evans CM; Garantziotis S; Adler KB; Dickey BF; du Bois RM; Yang IV; Herron A; Kervitsky D; Talbert JL; Markin C; Park J; Crews AL; Slifer SH; Auerbach S; Roy MG; Lin J; Hennessy CE; Schwarz MI; Schwartz DA
N Engl J Med; 2011 Apr; 364(16):1503-12. PubMed ID: 21506741
[TBL] [Abstract][Full Text] [Related]
5. Integrating Genomics Into Management of Fibrotic Interstitial Lung Disease.
Adegunsoye A; Vij R; Noth I
Chest; 2019 May; 155(5):1026-1040. PubMed ID: 30660786
[TBL] [Abstract][Full Text] [Related]
6. Resequencing Study Confirms That Host Defense and Cell Senescence Gene Variants Contribute to the Risk of Idiopathic Pulmonary Fibrosis.
Moore C; Blumhagen RZ; Yang IV; Walts A; Powers J; Walker T; Bishop M; Russell P; Vestal B; Cardwell J; Markin CR; Mathai SK; Schwarz MI; Steele MP; Lee J; Brown KK; Loyd JE; Crapo JD; Silverman EK; Cho MH; James JA; Guthridge JM; Cogan JD; Kropski JA; Swigris JJ; Bair C; Kim DS; Ji W; Kim H; Song JW; Maier LA; Pacheco KA; Hirani N; Poon AS; Li F; Jenkins RG; Braybrooke R; Saini G; Maher TM; Molyneaux PL; Saunders P; Zhang Y; Gibson KF; Kass DJ; Rojas M; Sembrat J; Wolters PJ; Collard HR; Sundy JS; O'Riordan T; Strek ME; Noth I; Ma SF; Porteous MK; Kreider ME; Patel NB; Inoue Y; Hirose M; Arai T; Akagawa S; Eickelberg O; Fernandez IE; Behr J; Mogulkoc N; Corte TJ; Glaspole I; Tomassetti S; Ravaglia C; Poletti V; Crestani B; Borie R; Kannengiesser C; Parfrey H; Fiddler C; Rassl D; Molina-Molina M; Machahua C; Worboys AM; Gudmundsson G; Isaksson HJ; Lederer DJ; Podolanczuk AJ; Montesi SB; Bendstrup E; Danchel V; Selman M; Pardo A; Henry MT; Keane MP; Doran P; Vašáková M; Sterclova M; Ryerson CJ; Wilcox PG; Okamoto T; Furusawa H; Miyazaki Y; Laurent G; Baltic S; Prele C; Moodley Y; Shea BS; Ohta K; Suzukawa M; Narumoto O; Nathan SD; Venuto DC; Woldehanna ML; Kokturk N; de Andrade JA; Luckhardt T; Kulkarni T; Bonella F; Donnelly SC; McElroy A; Armstong ME; Aranda A; Carbone RG; Puppo F; Beckman KB; Nickerson DA; Fingerlin TE; Schwartz DA
Am J Respir Crit Care Med; 2019 Jul; 200(2):199-208. PubMed ID: 31034279
[No Abstract] [Full Text] [Related]
7. Effect of Muc5b promoter polymorphism on disease predisposition and survival in idiopathic interstitial pneumonias.
van der Vis JJ; Snetselaar R; Kazemier KM; ten Klooster L; Grutters JC; van Moorsel CH
Respirology; 2016 May; 21(4):712-7. PubMed ID: 26699835
[TBL] [Abstract][Full Text] [Related]
8. Mucin 5B promoter polymorphism is associated with idiopathic pulmonary fibrosis but not with development of lung fibrosis in systemic sclerosis or sarcoidosis.
Stock CJ; Sato H; Fonseca C; Banya WA; Molyneaux PL; Adamali H; Russell AM; Denton CP; Abraham DJ; Hansell DM; Nicholson AG; Maher TM; Wells AU; Lindahl GE; Renzoni EA
Thorax; 2013 May; 68(5):436-41. PubMed ID: 23321605
[TBL] [Abstract][Full Text] [Related]
9. The MUC5B promoter polymorphism and telomere length in patients with chronic hypersensitivity pneumonitis: an observational cohort-control study.
Ley B; Newton CA; Arnould I; Elicker BM; Henry TS; Vittinghoff E; Golden JA; Jones KD; Batra K; Torrealba J; Garcia CK; Wolters PJ
Lancet Respir Med; 2017 Aug; 5(8):639-647. PubMed ID: 28648751
[TBL] [Abstract][Full Text] [Related]
10. An Exome Sequencing Study to Assess the Role of Rare Genetic Variation in Pulmonary Fibrosis.
Petrovski S; Todd JL; Durheim MT; Wang Q; Chien JW; Kelly FL; Frankel C; Mebane CM; Ren Z; Bridgers J; Urban TJ; Malone CD; Finlen Copeland A; Brinkley C; Allen AS; O'Riordan T; McHutchison JG; Palmer SM; Goldstein DB
Am J Respir Crit Care Med; 2017 Jul; 196(1):82-93. PubMed ID: 28099038
[TBL] [Abstract][Full Text] [Related]
11. Understanding Idiopathic Interstitial Pneumonia: A Gene-Based Review of Stressed Lungs.
van Moorsel CH; Hoffman TW; van Batenburg AA; Klay D; van der Vis JJ; Grutters JC
Biomed Res Int; 2015; 2015():304186. PubMed ID: 26539479
[TBL] [Abstract][Full Text] [Related]
12. Whole-exome sequencing identifies susceptibility genes and pathways for idiopathic pulmonary fibrosis in the Chinese population.
Fang C; Huang H; Feng Y; Zhang Q; Wang N; Jing X; Guo J; Ferianc M; Xu Z
Sci Rep; 2021 Jan; 11(1):1443. PubMed ID: 33446833
[TBL] [Abstract][Full Text] [Related]
13. Mucin 5B promoter polymorphism is associated with susceptibility to interstitial lung diseases in Chinese males.
Wang C; Zhuang Y; Guo W; Cao L; Zhang H; Xu L; Fan Y; Zhang D; Wang Y
PLoS One; 2014; 9(8):e104919. PubMed ID: 25121989
[TBL] [Abstract][Full Text] [Related]
14. Clinical features and genetic analysis of surfactant protein C in adult-onset familial interstitial pneumonia.
Setoguchi Y; Ikeda T; Fukuchi Y
Respirology; 2006 Jan; 11 Suppl():S41-5. PubMed ID: 16423270
[TBL] [Abstract][Full Text] [Related]
15. Extensive phenotyping of individuals at risk for familial interstitial pneumonia reveals clues to the pathogenesis of interstitial lung disease.
Kropski JA; Pritchett JM; Zoz DF; Crossno PF; Markin C; Garnett ET; Degryse AL; Mitchell DB; Polosukhin VV; Rickman OB; Choi L; Cheng DS; McConaha ME; Jones BR; Gleaves LA; McMahon FB; Worrell JA; Solus JF; Ware LB; Lee JW; Massion PP; Zaynagetdinov R; White ES; Kurtis JD; Johnson JE; Groshong SD; Lancaster LH; Young LR; Steele MP; Phillips Iii JA; Cogan JD; Loyd JE; Lawson WE; Blackwell TS
Am J Respir Crit Care Med; 2015 Feb; 191(4):417-26. PubMed ID: 25389906
[TBL] [Abstract][Full Text] [Related]
16. IDIOPATHIC PULMONARY FIBROSIS IS A COMPLEX GENETIC DISORDER.
Schwartz DA
Trans Am Clin Climatol Assoc; 2016; 127():34-45. PubMed ID: 28066036
[TBL] [Abstract][Full Text] [Related]
17. The pulmonary fibrosis-associated MUC5B promoter polymorphism does not influence the development of interstitial pneumonia in systemic sclerosis.
Peljto AL; Steele MP; Fingerlin TE; Hinchcliff ME; Murphy E; Podlusky S; Carns M; Schwarz M; Varga J; Schwartz DA
Chest; 2012 Dec; 142(6):1584-1588. PubMed ID: 22576636
[TBL] [Abstract][Full Text] [Related]
18. Genotype-Phenotype Relationships in Inheritable Idiopathic Pulmonary Fibrosis: A Greek National Cohort Study.
Manali ED; Kannengiesser C; Borie R; Ba I; Bouros D; Markopoulou A; Antoniou K; Kolilekas L; Papaioannou AI; Tzilas V; Tzouvelekis A; Daniil Z; Fouka E; Papakosta D; Xyfteri A; Karakatsani A; Loukides S; Korbila I; Tomos IP; Konstantinidis AK; Gogali A; Steiropoulos P; Papanikolaou IC; Bazaka C; Haritou A; Vassilakopoulos T; Maniati M; Kagouridis K; Markozannes E; Bouros E; Rampiadou C; Kounti G; Trachalaki A; Dimeas I; Karampitsakos T; Lyberopoulos P; Malamadakis N; Spyropoulou S; Revy P; Lainey E; Dieudé P; Rebah K; Ménard C; Oudin C; Masson C; Plessier A; Legendre M; Nathan N; Coulomb-L'Hermine A; Clement A; Amselem S; Boileau C; Crestani B; Papiris S;
Respiration; 2022; 101(6):531-543. PubMed ID: 35078193
[TBL] [Abstract][Full Text] [Related]
19. Overlap of Genetic Risk between Interstitial Lung Abnormalities and Idiopathic Pulmonary Fibrosis.
Hobbs BD; Putman RK; Araki T; Nishino M; Gudmundsson G; Gudnason V; Eiriksdottir G; Zilhao Nogueira NR; Dupuis J; Xu H; O'Connor GT; Manichaikul A; Nguyen J; Podolanczuk AJ; Madahar P; Rotter JI; Lederer DJ; Barr RG; Rich SS; Ampleford EJ; Ortega VE; Peters SP; O'Neal WK; Newell JD; Bleecker ER; Meyers DA; Allen RJ; Oldham JM; Ma SF; Noth I; Jenkins RG; Maher TM; Hubbard RB; Wain LV; Fingerlin TE; Schwartz DA; Washko GR; Rosas IO; Silverman EK; Hatabu H; Cho MH; Hunninghake GM
Am J Respir Crit Care Med; 2019 Dec; 200(11):1402-1413. PubMed ID: 31339356
[No Abstract] [Full Text] [Related]
20. Exploration of the MUC5B promoter variant and ILD risk in patients with autoimmune myositis.
Johnson C; Rosen P; Lloyd T; Horton M; Christopher-Stine L; Oddis CV; Mammen AL; Danoff SK
Respir Med; 2017 Sep; 130():52-54. PubMed ID: 29206633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
